1. Home
  2. NRSN vs BGSF Comparison

NRSN vs BGSF Comparison

Compare NRSN & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • BGSF
  • Stock Information
  • Founded
  • NRSN 2017
  • BGSF 2007
  • Country
  • NRSN Israel
  • BGSF United States
  • Employees
  • NRSN N/A
  • BGSF N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • BGSF Professional Services
  • Sector
  • NRSN Health Care
  • BGSF Consumer Discretionary
  • Exchange
  • NRSN Nasdaq
  • BGSF Nasdaq
  • Market Cap
  • NRSN 58.8M
  • BGSF 47.7M
  • IPO Year
  • NRSN 2021
  • BGSF N/A
  • Fundamental
  • Price
  • NRSN $1.91
  • BGSF $6.24
  • Analyst Decision
  • NRSN Buy
  • BGSF Strong Buy
  • Analyst Count
  • NRSN 2
  • BGSF 1
  • Target Price
  • NRSN $14.00
  • BGSF $9.00
  • AVG Volume (30 Days)
  • NRSN 442.8K
  • BGSF 233.6K
  • Earning Date
  • NRSN 07-11-2025
  • BGSF 08-06-2025
  • Dividend Yield
  • NRSN N/A
  • BGSF N/A
  • EPS Growth
  • NRSN N/A
  • BGSF N/A
  • EPS
  • NRSN N/A
  • BGSF N/A
  • Revenue
  • NRSN N/A
  • BGSF $266,968,000.00
  • Revenue This Year
  • NRSN N/A
  • BGSF $0.59
  • Revenue Next Year
  • NRSN N/A
  • BGSF N/A
  • P/E Ratio
  • NRSN N/A
  • BGSF N/A
  • Revenue Growth
  • NRSN N/A
  • BGSF N/A
  • 52 Week Low
  • NRSN $0.51
  • BGSF $2.91
  • 52 Week High
  • NRSN $2.60
  • BGSF $9.22
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 51.18
  • BGSF 78.79
  • Support Level
  • NRSN $2.04
  • BGSF $5.28
  • Resistance Level
  • NRSN $2.35
  • BGSF $5.90
  • Average True Range (ATR)
  • NRSN 0.25
  • BGSF 0.42
  • MACD
  • NRSN -0.04
  • BGSF 0.13
  • Stochastic Oscillator
  • NRSN 28.74
  • BGSF 82.59

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

Share on Social Networks: